USPTO serial 79435359
PHARMA GUARDRAILS
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- AURAND, MEGAN LEE
- Law office
- TMO LAW OFFICE 128
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHARMA GUARDRAILS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian E. Ainsworth
Brian E. Ainsworth Price Heneveld LLP3400 Innovation Court SEP.O. Box 2567Grand Rapids, MI 49512Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | SOFTWARE FOR CONTROLLING INDUSTRIAL PROCESSES, PARTICULARLY IN THE PHARMACEUTICAL SECTOR · SOFTWARE FOR ANALYSING COMPANY AND PROCESS DATA WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · ARTIFICIAL INTELLIGENCE SOFTWARE FOR HEALTHCARE · SOFTWARE FOR DATA AND FILE MANAGEMENT AND FOR DATABASES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR [PROCESS] DATA MANAGEMENT WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR [PROCESS] DATA VISUALISATION WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR AUTOMATED REPORTING WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR CONTROLLING MACHINES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR SUPPLY CHAIN MANAGEMENT WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR FACTORY AUTOMATION, PARTICULARLY IN THE PHARMACEUTICAL INDUSTRY · DOWNLOADABLE MOBILE APPLICATIONS FOR THE TRANSFER OF INFORMATION WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · APPLICATION SOFTWARE FOR MOBILE DEVICES · SOFTWARE FOR THE AUTOMATION OF ROBOTIC PROCESSES [RPA] WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR INDUSTRIAL AUTOMATION, PARTICULARLY IN THE PHARMACEUTICAL INDUSTRY · SOFTWARE FOR PRODUCTION MANAGEMENT SYSTEMS WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR THE PHARMACEUTICAL AND BIOTECH INDUSTRY · SOFTWARE FOR THE LIFE SCIENCES INDUSTRY · SOFTWARE FOR CELL AND GENE THERAPY PRODUCTION · SOFTWARE FOR QUALITY CONTROL AND ASSURANCE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR THE DOCUMENTATION AND REPORTING OF PRODUCTION PROCESSES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR ARTIFICIAL INTELLIGENCE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · INTERACTIVE SOFTWARE BASED ON ARTIFICIAL INTELLIGENCE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · ARTIFICIAL INTELLIGENCE SOFTWARE FOR THE CREATION OF ANALYSES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · ARTIFICIAL INTELLIGENCE SOFTWARE FOR MONITORING WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR PRODUCT LIFECYCLE MANAGEMENT WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR DRUG AND DRUG DISCOVERY DEVELOPMENT · SOFTWARE FOR PROCESS DEVELOPMENT IN DRUG MANUFACTURING · MANUFACTURING EXECUTION SYSTEM [MULTI-LAYERED PRODUCTION MANAGEMENT SYSTEM, MES] FOR THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY, IN PARTICULAR SOFTWARE FOR MONITORING, CONTROLLING AND OPTIMISING PRODUCTION PROCESSES IN PHARMACEUTICAL COMPANIES · MANUFACTURING EXECUTION SYSTEM [MULTI-LAYER PRODUCTION MANAGEMENT SYSTEM, MES] FOR THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY, IN PARTICULAR SOFTWARE FOR THE INTEGRATION AND APPLICATION OF ARTIFICIAL INTELLIGENCE FOR CONTROL, OPTIMISATION AND DECISION SUPPORT IN PRODUCTION PROCESSES IN PHARMACEUTICAL COMPANIES · SOFTWARE FOR THE VALIDATION OF AI-GENERATED STATEMENTS, PARTICULARLY IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, PARTICULARLY THE PHARMACEUTICAL INDUSTRY, PARTICULARLY IN COMPLIANCE WITH ALCOA PRINCIPLES · SOFTWARE FOR THE DETERMINISTIC VALIDATION OF AI-GENERATED STATEMENTS, IN PARTICULAR STATEMENTS GENERATED BY GENERATIVE AI [GENAI], PARTICULARLY IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY · SOFTWARE FOR THE VALIDATION OF AI-GENERATED OR AI-BASED RESULTS, IN PARTICULAR BY MEANS OF MULTI-AGENT VALIDATION WITH TURING EVALUATION WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR OPERATING ROBOTS, PARTICULARLY IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, PARTICULARLY THE PHARMACEUTICAL INDUSTRY · SOFTWARE FOR OPERATING ROBOTS, PARTICULARLY IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, PARTICULARLY THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · SOFTWARE FOR VERIFYING DATA OR SENSOR DATA FROM ROBOTS, PARTICULARLY IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, NAMELY WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR VERIFYING DATA OR SENSOR DATA FROM ROBOTS, PARTICULARLY MULTIMODAL DATA OR SENSOR DATA FROM ROBOTS WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR VERIFYING DATA OR SENSOR DATA FROM ROBOTS, PARTICULARLY ROBOTS USED IN THE PHARMACEUTICAL INDUSTRY · SOFTWARE FOR VERIFYING DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR ROBOTS USED IN THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES INVOLVED IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · SOFTWARE FOR OPERATING AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY · SOFTWARE FOR OPERATING AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · SOFTWARE FOR VERIFYING DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, NAMELY WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR VERIFYING DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR MULTIMODAL DATA OR SENSOR DATA FROM AR DEVICES NAMELY WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE FOR VERIFYING DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES USED IN THE PHARMACEUTICAL INDUSTRY · SOFTWARE FOR VERIFYING DATA OR SENSOR DATA FROM AUGMENTED REALITY (AR) DEVICES, IN PARTICULAR FROM AR DEVICES USED IN THE PHARMACEUTICAL INDUSTRY OR IN PROCESSES INVOLVED IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS. | ACTIVE | — |
| 041 | EDUCATION · TRAINING · ENTERTAINMENT · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS IN THE FIELDS OF MANUFACTURING EXECUTION SYSTEM (MES) SOLUTIONS (MULTI-SHIFT PRODUCTION MANAGEMENT SYSTEM) FOR THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS IN THE FIELDS OF SOFTWARE SOLUTIONS BASED ON ARTIFICIAL INTELLIGENCE FOR THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VALIDATION OF AI-GENERATED STATEMENTS, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY, IN PARTICULAR IN COMPLIANCE WITH ALCOA PRINCIPLES · TRAINING AND CONTINUING EDUCATION, PARTICULARLY FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE DETERMINISTIC VALIDATION OF AI-GENERATED STATEMENTS, PARTICULARLY THOSE GENERATED BY GENERATIVE AI [GENAI], PARTICULARLY IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, PARTICULARLY THE PHARMACEUTICAL INDUSTRY · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VALIDATION OF AI-GENERATED OR AI-BASED RESULTS, IN PARTICULAR BY MEANS OF MULTI-AGENT VALIDATION WITH TURING EVALUATION · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE OPERATION OF ROBOTS, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE OPERATION OF ROBOTS, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR MULTIMODAL DATA OR SENSOR DATA FROM ROBOTS · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR ROBOTS USED IN THE PHARMACEUTICAL INDUSTRY · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR FROM ROBOTS USED IN THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE OPERATION OF AUGMENTED REALITY (AR) DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE OPERATION OF AUGMENTED REALITY (AR) DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM AUGMENTED REALITY (AR) DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM AUGMENTED REALITY (AR) DEVICES, IN PARTICULAR MULTIMODAL DATA OR SENSOR DATA FROM AR DEVICES · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR DATA OR SENSOR DATA FROM AUGMENTED REALITY (AR) DEVICES IN THE PHARMACEUTICAL INDUSTRY · TRAINING AND FURTHER EDUCATION, IN PARTICULAR FOR USERS AND SPECIALISTS OF SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM AUGMENTED REALITY (AR) DEVICES, IN PARTICULAR FROM AR DEVICES USED IN THE PHARMACEUTICAL INDUSTRY OR IN PROCESSES INVOLVED IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS. | ACTIVE | — |
| 042 | SCIENTIFIC AND TECHNOLOGICAL SERVICES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DESIGN SERVICES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · INDUSTRIAL ANALYSIS AND RESEARCH SERVICES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · CONSULTING IN THE FIELD OF CHEMISTRY, BIOTECHNOLOGY AND BIOCHEMISTRY WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · MANUFACTURING EXECUTION SYSTEM [MULTI-LAYERED PRODUCTION MANAGEMENT SYSTEM, MES] FOR THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY, PROVIDED IN THE FORM OF SOFTWARE AS A SERVICE · SOFTWARE AS A SERVICE [SAAS] IN RELATION TO SOFTWARE FOR THE MANAGEMENT OF PHARMACEUTICAL PRODUCTION PROCESSES · SOFTWARE AS A SERVICE [SAAS] RELATING TO SOFTWARE FOR THE ADAPTATION AND OPTIMISATION OF PROCESS TECHNOLOGY AND PRODUCTION PLATFORMS FOR THE MANUFACTURE OF PHARMACEUTICALS · TECHNICAL CONSULTING SERVICES RELATING TO THE MANUFACTURE OF PHARMACEUTICALS · SCIENTIFIC RESEARCH WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · TECHNICAL SUPPORT, NAMELY TROUBLESHOOTING AND REPAIR OF COMPUTER HARDWARE AND SOFTWARE PROBLEMS WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE CREATION AND DESIGN WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE DEVELOPMENT WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DESIGN OF COMPUTER DATABASES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · TECHNICAL DATA ANALYSIS WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · CLOUD COMPUTING WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SOFTWARE AS A SERVICE [SAAS] WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · PLATFORM AS A SERVICE [PAAS] WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · APPLICATION SERVICE PROVIDER [ASP] SERVICES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · IT SERVICES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DESIGN OF INFORMATION SYSTEMS WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · HOSTING OF COMPUTER DATABASES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · WEB HOSTING WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · ONLINE PROVISION OF NON-DOWNLOADABLE SOFTWARE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · PROVISION OF TEMPORARY USE OF NON- DOWNLOADABLE SOFTWARE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · TECHNOLOGICAL CONSULTING SERVICES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · SCIENTIFIC CONSULTING SERVICES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · CONSULTING SERVICES RELATING TO PRODUCT DEVELOPMENT WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · PROFESSIONAL CONSULTING RELATING TO COMPUTER SOFTWARE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · CONSULTING IN THE FIELD OF INFORMATION TECHNOLOGY, IN PARTICULAR IN THE FIELD OF DIGITAL TRANSFORMATION WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DEVELOPMENT OF COMPUTER SYSTEMS IN THE PHARMACEUTICAL AND BIOTECH INDUSTRY · RESEARCH SERVICES IN THE PHARMACEUTICAL AND BIOTECH INDUSTRY · DEVELOPMENT OF COMPUTER SYSTEMS IN THE FIELD OF LIFE SCIENCES · DEVELOPMENT OF COMPUTER SYSTEMS IN THE FIELD OF CELL AND GENE THERAPY PRODUCTION · DEVELOPMENT OF COMPUTER SYSTEMS IN THE FIELD OF QUALITY CONTROL AND ASSURANCE · DEVELOPMENT OF COMPUTER SYSTEMS IN THE FIELD OF DOCUMENTATION AND REPORTING OF PRODUCTION PROCESSES WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DEVELOPMENT OF COMPUTER SYSTEMS, IN PARTICULAR FOR INTEGRATED PROCESS MODELS WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DEVELOPMENT OF COMPUTER SYSTEMS, IN PARTICULAR DIGITAL TWINS WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · RESEARCH IN THE FIELD OF ARTIFICIAL INTELLIGENCE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · CONSULTING IN THE FIELD OF ARTIFICIAL INTELLIGENCE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · TECHNOLOGY CONSULTING IN THE FIELD OF ARTIFICIAL INTELLIGENCE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · PROVISION OF COMPUTER PROGRAMS FOR ARTIFICIAL INTELLIGENCE IN DATA NETWORKS WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · PLATFORMS FOR ARTIFICIAL INTELLIGENCE AS SOFTWARE AS A SERVICE [SAAS] WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DEVELOPMENT OF MANUFACTURING EXECUTION SYSTEM (MES) SOLUTIONS (MULTI-LAYERED PRODUCTION MANAGEMENT SYSTEM) FOR THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY, IN PARTICULAR SOFTWARE FOR MONITORING, CONTROLLING AND OPTIMISING PRODUCTION PROCESSES IN PHARMACEUTICAL COMPANIES · DEVELOPMENT OF MANUFACTURING EXECUTION SYSTEM (MES) SOLUTIONS FOR THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY, IN PARTICULAR SOFTWARE FOR THE INTEGRATION AND APPLICATION OF ARTIFICIAL INTELLIGENCE FOR CONTROL, OPTIMISATION AND DECISION SUPPORT IN PRODUCTION PROCESSES IN PHARMACEUTICAL COMPANIES · CONSULTING, IMPLEMENTATION AND SUPPORT FOR MANUFACTURING EXECUTION SYSTEM [MES] SOLUTIONS FOR THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY · MAINTENANCE AND OPTIMISATION SERVICES FOR MANUFACTURING EXECUTION SYSTEM [MES] SOLUTIONS AND SOFTWARE SOLUTIONS BASED ON ARTIFICIAL INTELLIGENCE WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VALIDATION OF AI-GENERATED STATEMENTS, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY, IN PARTICULAR IN COMPLIANCE WITH ALCOA PRINCIPLES · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE DETERMINISTIC VALIDATION OF AI-GENERATED STATEMENTS, IN PARTICULAR STATEMENTS GENERATED BY GENERATIVE AI (GENAI), PARTICULARLY IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VALIDATION OF AI-GENERATED OR AI-BASED RESULTS, IN PARTICULAR BY MEANS OF MULTI-AGENT VALIDATION WITH TURING EVALUATION WITHIN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE SECTORS · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE OPERATION OF ROBOTS, PARTICULARLY IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, PARTICULARLY THE PHARMACEUTICAL INDUSTRY · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE OPERATION OF ROBOTS, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR IN REGULATED AND SAFETY- CRITICAL INDUSTRIES, IN PARTICULAR IN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE INDUSTRIES · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR MULTIMODAL DATA OR SENSOR DATA FROM ROBOTS , IN PARTICULAR IN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE INDUSTRIES · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR ROBOTS USED IN THE PHARMACEUTICAL INDUSTRY · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM ROBOTS, IN PARTICULAR ROBOTS USED IN THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE OPERATION OF AUGMENTED REALITY (AR) DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE OPERATION OF AUGMENTED REALITY (AR) DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES, IN PARTICULAR THE PHARMACEUTICAL INDUSTRY IN CONNECTION WITH PROCESSES IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR IN REGULATED AND SAFETY-CRITICAL INDUSTRIES , IN PARTICULAR IN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE INDUSTRIES · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR MULTIMODAL DATA OR SENSOR DATA FROM AR DEVICES , IN PARTICULAR IN THE PHARMACEUTICAL, BIOTECH AND LIFE SCIENCE INDUSTRIES · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES IN THE PHARMACEUTICAL INDUSTRY · DEVELOPMENT, CONSULTING, IMPLEMENTATION, MAINTENANCE, OPTIMISATION AND/OR SUPPORT OF OR FOR SOFTWARE FOR THE VERIFICATION OF DATA OR SENSOR DATA FROM AUGMENTED REALITY [AR] DEVICES, IN PARTICULAR FROM AR DEVICES USED IN THE PHARMACEUTICAL INDUSTRY OR IN PROCESSES INVOLVED IN THE MANUFACTURE, FILLING, PACKAGING OR STORAGE OF ADVANCED THERAPY MEDICINAL PRODUCTS. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 6, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 5, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 28, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |